Kathleen Peindl
- 3Articles
- 4.5KReads
- 2006–2008Active
- 8Collaborators
- 48Citations
About
Kathleen Peindl has authored research on the treatment of major depressive disorder and anxiety, focusing on pharmacologic interventions such as escitalopram, aripiprazole, and paroxetine. Her work includes clinical trials and post hoc analyses examining drug response in conditions including treatment-resistant depression and irritable bowel syndrome with comorbid mood disorders. Peindl's publications appeared between 2006 and 2008 in Psychiatrist.com journals.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
